Furthermore, these assays could play a key role in bridging the gap between preclinical toxicology studies in animal models and clinical investigations.
A Colony Forming Unit-Megakaryocyte (CFU-Mk) assay in human progenitors has also been prevalidated for testing the drug toxicity on megakaryocytes.